Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company developing the next generation of therapeutics based on its proprietary self-delivering RNAi (INTASYL™)...

Gracell to present first-in-human data on GC502, an allogeneic CD19/CD7 dual-directed chimeric antigen receptor (CAR) T cell therapy PALO ALTO, Calif. and SUZHOU, China, March 8, 2022 /PRNewswire/ --

PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the Company will present the updated data of...

One of the hottest areas in medtech is being featured as a key panel at the life science industry's premiere investor summit. Life Science Intelligence, a market intelligence & consulting company...

Spark Networks SE (NASDAQ: LOV), a leading social dating platform for meaningful relationships, today announced that Company management will be hosting meetings with investors on March 15, 2022...